Dr. Michael David Hein, M.D. Internal Medicine - Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 2 Wake Robin Rd, Suite 207, Lincoln, RI 02865 Phone: 401-334-2242 Fax: 401-334-0376 |
News Archive
Opioid addiction has been increasing over the last decade or so in the US, with many deaths occurring as a result of opioid overdose. As a result, many programs have been set up to deal with this addiction using medications like buprenorphine. This is one of the three approved drugs that are used for this condition, and the most useful one.
The Clinical Addiction Research and Education Unit in the Section of General Internal Medicine at BMC was recently awarded a $1,886,087 renewal grant from the National Institutes of Health to expand its education of physicians-in-training to become sophisticated implementers of substance use screening, assessment and treatment research.
The U.S. Food and Drug Administration (FDA) today approved Zyprexa® (olanzapine) in tablet form as an option for the treatment of schizophrenia and manic or mixed episodes associated with bipolar I disorder in adolescents aged 13-17 years old.
A new centre dedicated to the understanding and treatment of neurodegenerative diseases will be established at UCL following the award of a -20million grant from the Wolfson Foundation, it was announced today.
› Verified 6 days ago